SYRS Archived Articles
Syros Pharmaceuticals (SYRS): A Biopharmaceutical Firm Committed to Advancing Hematologic Malignancy Treatments
Published on November 30, 2024
Syros (NASDAQ:SYRS) Poised for Potential Breakthrough in Hematologic Malignancies
Published on September 24, 2024